China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

SZSE:000999 Stock Report

Market Cap: CN¥56.7b

China Resources Sanjiu Medical & Pharmaceutical Future Growth

Future criteria checks 1/6

China Resources Sanjiu Medical & Pharmaceutical is forecast to grow earnings and revenue by 11.2% and 8.8% per annum respectively. EPS is expected to grow by 11.5% per annum. Return on equity is forecast to be 18% in 3 years.

Key information

11.2%

Earnings growth rate

11.5%

EPS growth rate

Pharmaceuticals earnings growth18.2%
Revenue growth rate8.8%
Future return on equity18.0%
Analyst coverage

Good

Last updated20 Jan 2025

Recent future growth updates

Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

Aug 26
Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Recent updates

Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Trading At A 39% Discount?

Jan 03
Is China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Trading At A 39% Discount?

Little Excitement Around China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Nov 18
Little Excitement Around China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

Aug 26
Analysts Are Updating Their China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Estimates After Its Second-Quarter Results

Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?

Aug 09
Does China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Have A Healthy Balance Sheet?

Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Jul 12
Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50

Jun 09
China Resources Sanjiu Medical & Pharmaceutical (SZSE:000999) Is Increasing Its Dividend To CN¥1.50

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Apr 23
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued

Apr 16
An Intrinsic Calculation For China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SZSE:000999) Suggests It's 50% Undervalued

Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Mar 20
Investors Aren't Buying China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.'s (SZSE:000999) Earnings

Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?

Feb 28
Do China Resources Sanjiu Medical & Pharmaceutical's (SZSE:000999) Earnings Warrant Your Attention?

Earnings and Revenue Growth Forecasts

SZSE:000999 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202733,3964,6994,038N/A2
12/31/202633,8474,3734,5075,74711
12/31/202530,9073,8683,4494,56712
12/31/202427,0883,3882,5993,30611
9/30/202425,8713,4103,5754,346N/A
3/31/202425,6813,0663,8974,677N/A
12/31/202324,7392,8533,3354,192N/A
9/30/202324,5772,8993,0684,039N/A
6/30/202322,8252,8931,8542,876N/A
3/31/202320,1822,7591,8562,858N/A
1/1/202318,0792,4492,0553,006N/A
9/30/202216,3932,2511,5992,448N/A
6/30/202216,0812,1121,9192,734N/A
3/31/202215,7152,2531,2542,055N/A
1/1/202215,5442,0551,0121,885N/A
9/30/202115,5861,7731,2992,133N/A
6/30/202115,6231,9191,4892,213N/A
3/31/202114,5561,7171,1121,857N/A
12/31/202013,6371,5971,6022,224N/A
9/30/202013,9201,7101,3461,976N/A
6/30/202013,5051,4311,2031,828N/A
3/31/202014,4731,4551,7412,263N/A
12/31/201914,7942,0991,4111,949N/A
9/30/201914,1712,2891,4471,906N/A
6/30/201914,1222,3281,5172,012N/A
3/31/201913,5302,1761,3962,009N/A
12/31/201813,4281,4321,3111,911N/A
9/30/201813,0801,4551,3581,943N/A
6/30/201812,5941,387N/A1,906N/A
3/31/201812,0431,350N/A1,697N/A
12/31/201711,1201,302N/A1,599N/A
9/30/201710,3011,288N/A1,577N/A
6/30/20179,6991,303N/A1,459N/A
3/31/20179,3071,260N/A1,347N/A
12/31/20168,9821,198N/A1,392N/A
9/30/20168,5531,290N/A1,335N/A
6/30/20168,4851,258N/A1,320N/A
3/31/20168,1491,223N/A1,341N/A
12/31/20157,9001,249N/A1,260N/A
9/30/20157,7091,160N/A1,338N/A
6/30/20157,4751,107N/A1,330N/A
3/31/20157,4121,086N/A1,213N/A
12/31/20147,2771,036N/A1,184N/A
9/30/20146,770938N/A1,105N/A
6/30/20146,9591,064N/A1,152N/A
3/31/20147,1961,058N/A1,177N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 000999's forecast earnings growth (11.2% per year) is above the savings rate (2.8%).

Earnings vs Market: 000999's earnings (11.2% per year) are forecast to grow slower than the CN market (25.2% per year).

High Growth Earnings: 000999's earnings are forecast to grow, but not significantly.

Revenue vs Market: 000999's revenue (8.8% per year) is forecast to grow slower than the CN market (13.4% per year).

High Growth Revenue: 000999's revenue (8.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 000999's Return on Equity is forecast to be low in 3 years time (18%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/22 10:28
End of Day Share Price 2025/01/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is covered by 39 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Changming HeBOCI Research Ltd.
Jessica LiBofA Global Research
Shuchang LiuChangjiang Securities Co. LTD.